Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Thyroid Carcinoma, Anaplastic × selpercatinib × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 3 Carcinoma, Medullary 3 Thyroid Neoplasms 2 Sarcoma 2 Wilms Tumor 1 Thyroid Diseases 1 Thyroid Cancer, Papillary 1 Thoracic Neoplasms 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Osteosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Neoplasms by Site 1 Neoplasms 1 Myofibromatosis 1 Medulloblastoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Lung Neoplasms 1 Lung Diseases 1 Histiocytosis, Langerhans-Cell 1 Hepatoblastoma 1 Head and Neck Neoplasms 1 Glioma 1 Ependymoma 1 Endocrine System Diseases 1

Interventions

Paclitaxel 3 pembrolizumab 2 efatutazone 2 trametinib 1 tislelizumab 1 surufatinib 1 spartalizumab 1 sapanisertib 1 pazopanib 1 lenvatinib 1 fosbretabulin 1 dabrafenib 1 crolibulin 1 combretastatin 1 cabozantinib 1 atezolizumab 1 abemaciclib 1 Sorafenib 1 Radiotherapy, Intensity-Modulated 1 Imatinib Mesylate 1 Gefitinib 1 Doxorubicin 1 Docetaxel 1 Cisplatin 1 Carboplatin 1 CUDC-907 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡